BACSIKEN Trademark

Trademark Overview

On Thursday, October 25, 2018, a trademark application was filed for BACSIKEN with the United States Patent and Trademark Office. The USPTO has given the BACSIKEN trademark a serial number of 88168817. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 28, 2022. This trademark is owned by Novartis AG. The BACSIKEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use, namely, muscle relaxants
bacsiken

General Information

Serial Number88168817
Word MarkBACSIKEN
Filing DateThursday, October 25, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 28, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 25, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use, namely, muscle relaxants
Translation of Words in MarkThe word "BACSIKEN" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 8, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4002
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, March 28, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 28, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, August 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 5, 2021EXTENSION 5 GRANTED
Tuesday, August 3, 2021EXTENSION 5 FILED
Tuesday, August 3, 2021TEAS EXTENSION RECEIVED
Tuesday, February 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 12, 2021EXTENSION 4 GRANTED
Friday, February 12, 2021EXTENSION 4 FILED
Friday, February 12, 2021TEAS EXTENSION RECEIVED
Tuesday, August 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 14, 2020EXTENSION 3 GRANTED
Friday, August 14, 2020EXTENSION 3 FILED
Friday, August 14, 2020TEAS EXTENSION RECEIVED
Saturday, February 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 28, 2020EXTENSION 2 GRANTED
Tuesday, February 18, 2020EXTENSION 2 FILED
Friday, February 28, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 18, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 18, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 18, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 18, 2020TEAS EXTENSION RECEIVED
Saturday, August 17, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 15, 2019EXTENSION 1 GRANTED
Thursday, August 15, 2019EXTENSION 1 FILED
Thursday, August 15, 2019TEAS EXTENSION RECEIVED
Tuesday, February 19, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 25, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 25, 2018PUBLISHED FOR OPPOSITION
Wednesday, December 5, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 15, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 13, 2018ASSIGNED TO EXAMINER
Thursday, November 8, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 29, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

bacsiken muscle relaxants namely human preparations pharmaceutical